Bromide

Bromide

SCHEMBL478157

Br.CC(N)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL728201 0.95
SCHEMBL8227653 0.94
SCHEMBL13208844 0.94
SCHEMBL15047 0.94
Water SCHEMBL1245230 0.89
SCHEMBL7791323 0.89
SCHEMBL1524317 0.89
Iodide SCHEMBL5874467 0.89
SCHEMBL2035844 0.89
SCHEMBL4311063 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112794822-B Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application 北京师范大学(CN) 2023-01-13 CN claimed
CN-112794822-A Cationic N-substituted aniline ionic liquid, polyionic liquid thereof, preparation method and application 北京师范大学 2021-05-14 CN claimed
CN-111100070-A Cationic N-substituted aniline ionic liquid and preparation method thereof 北京师范大学 2020-05-05 CN claimed
EP-2410988-A1 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA Novartis AG (CH) 2012-02-01 EP claimed
JP-4838514-B2 2011-12-14 JP claimed
WO-2011108955-A1 MULTI -TARGETING SYSTEM COMPRISING A NANOCARRIER, NUCLEIC ACID(S) AND NON-NUCLEIC ACID BASED DRUG(S) UNIVERSIDADE DE COIMBRA (PT) 2011-09-09 WO claimed
WO-2010108934-A1 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG AND SIRNA NOVARTIS AG (CH) 2010-09-30 WO claimed
EP-2152274-A1 NASAL ADMINISTRATION OF BENZODIAZEPINES Questor Pharmaceuticals, Inc. (US) 2010-02-17 EP claimed
WO-2008137960-A1 NASAL ADMINISTRATION OF BENZODIAZEPINES QUESTOR PHARMACEUTICALS, INC. (US) 2008-11-13 WO claimed
EP-1658053-A2 NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE Elan Pharma International Limited (IE) 2006-05-24 EP claimed
EP-1613276-A1 LOW VISCOSITY LIQUID DOSAGE FORMS Elan Pharma International Limited (IE) 2006-01-11 EP claimed
EP-1596830-A1 NOVEL FLUTICASONE FORMULATIONS Elan Pharma International Limited (IE) 2005-11-23 EP claimed
WO-2005013937-A2 NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE ELAN PHARMA INTERNATIONAL LTD. (IE) 2005-02-17 WO claimed
WO-2004069225-A1 NOVEL FLUTICASONE FORMULATIONS ELAN PHARMA INTERNATIONAL LTD. (IE) 2004-08-19 WO claimed
WO-2004050059-A1 LOW VISCOSITY LIQUID DOSAGE FORMS ELAN PHARMA INTERNATIONAL LTD. (IE) 2004-06-17 WO claimed
US-4777297-A ETHERIFICATION IN ALKALINE SOLUTION WITH BROMIDE OR IODIDE MARUBISHI YUKA KOGYO KABUSHIKI KAISHA (JP) 1988-10-11 US claimed
EP-4709842-A1 SERUM-FREE AND XENO-FREE CULTURE MEDIUM FOR EXPANDING MESENCHYMAL STEM CELLS Nuwacell Biotechnologies Co., Ltd. (CN) 2026-03-18 EP disclosed
US-12507340-B2 Resin film with conductor layer, multilayer substrate, and method for producing resin film with conductor layer MURATA MANUFACTURING CO., LTD. (JP) 2025-12-23 US disclosed
US-4126685-A 6-Aryl-pyrrolo[1,2,9]imidazole derivatives which possess anti-hypertensive activity IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1978-11-21 US disclosed
US-4098621-A Soldering fluxes FRY'S METALS LIMITED (GB) 1978-07-04 US disclosed